This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Enalare Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Robert B. Raffa: Inventor of Large-Conductance Potassium Channel Modulators.
Introduction
Robert B. Raffa is an inventor associated with Tucson, Arizona, and Enalare Therapeutics Inc. His patent work concerns compounds and pharmaceutical approaches targeting large-conductance potassium channels.
Latest Patents
Raffa is credited with 1 patent: “Large-Conductance Potassium Channel Modulators, Compositions Thereof, Methods of Manufacturing Thereof, and Methods of Use Thereof.” The patent describes methods for treating diseases or conditions modulated by these channels by administering an effective amount of a modulating compound. Potential applications include protection against ischemia and hypoxia in different parts of the body, as well as stimulation of respiration under such conditions. It also describes pharmaceutical compositions and methods for preparing them.
Career Highlights
Raffa’s listed invention focuses on therapeutic applications of potassium channel modulation. The disclosed work encompasses both treatment methods and the development and preparation of related pharmaceutical compositions.
Collaborations
Raffa is associated with Enalare Therapeutics Inc. His listed coworker is Joseph V. Pergolizzi.
Conclusion
Robert B. Raffa’s patent highlights research into large-conductance potassium channel modulators and their potential use in addressing ischemia, hypoxia, and related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile